Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 36,133 | $0.22 | $7,949 | 0 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 12,099 | $0.1969 | $2,382 | 0 (Direct) | View |
| 2024-11-19 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic | 46,657 | $0.2212 | $10,321 | 0 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 134,797 | $0.1998 | $26,932 | 0 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 137,803 | $0.2103 | $28,980 | 0 (Direct) | View |
| 2024-09-10 Purchase | 2024-09-12 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 100,000 | $1.6124 | $161,240 | 124,552 (Direct) | View |
| 2024-09-10 Purchase | 2024-09-12 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 100,000 | $1.6068 | $160,680 | 122,504 (Direct) | View |
| 2024-06-28 Sale | 2024-07-02 4:15 pm | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 34,837 | $5.12 | $178,365 | 8,000 (Direct) | View |
| 2024-04-03 Sale | 2024-04-05 4:30 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 10,451 | $4.95 | $51,732 | 0 (Direct) | View |
| 2024-04-02 Sale | 2024-04-02 4:58 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 150 | $4.9803 | $747 | 41,118 (Direct) | View |
| 2023-12-21 Purchase | 2023-12-26 5:24 pm | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 904,977 | $4.42 | $3,999,998 | 1,789,093 (Indirect Direct) | View |
| 2023-12-12 Sale | 2023-12-14 4:24 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,287 | $4.95 | $31,121 | 0 (Direct) | View |
| 2023-12-06 Sale | 2023-12-08 4:23 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,287 | $3.95 | $24,834 | 6,287 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Exercise | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 40,125 | $0 | 175,783 (Direct) | View |
| 2024-10-31 Tax Withholding | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,776 | $2.09 | 12,099 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 18,875 | $0 | 12,099 (Direct) | View |
| 2024-10-31 Tax Withholding | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 5,624 | $2.09 | 137,803 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 18,875 | $0 | 137,803 (Direct) | View |
| 2024-10-31 Tax Withholding | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 8,707 | $2.09 | 130,797 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 17,000 | $0 | 130,797 (Direct) | View |
| 2024-10-31 Tax Withholding | 2024-11-04 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 6,104 | $2.09 | 36,133 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 17,000 | $0 | 36,133 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic | 3,100 | $2.1 | 66,657 (Direct) | View |
| 2024-09-30 Exercise | 2024-10-02 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic | 10,000 | $0 | 66,657 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 2,667 | $0 | 12,000 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 2,667 | $0 | 13,334 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 10,000 | $0 | 141,658 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director | 10,000 | $0 | 48,837 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director | 10,000 | $0 | 39,189 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director | 10,000 | $0 | 22,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director | 10,000 | $0 | 22,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director | 10,000 | $0 | 22,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director | 10,000 | $0 | 22,000 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:42 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 4,000 | $0 | 12,000 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:41 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 4,000 | $0 | 6,666 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 4,218 | $5.12 | 52,571 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 13,666 | $0 | 52,571 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:59 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 14,052 | $5.12 | 222,792 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:59 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 45,566 | $0 | 222,792 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 4,732 | $5.12 | 41,118 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 15,333 | $0 | 41,118 (Direct) | View |
| 2024-03-28 Tax Withholding | 2024-04-02 4:57 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic | 7,046 | $5.59 | 39,757 (Direct) | View |
| 2024-03-27 Exercise | 2024-04-02 4:57 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic | 22,500 | $0 | 39,757 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 4,732 | $5.12 | 55,219 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer | 15,333 | $0 | 55,219 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 3,500 | $5.12 | 49,838 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 13,666 | $0 | 49,838 (Direct) | View |
| 2023-12-02 Option Award | 2023-12-05 5:28 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 86,000 | $0 | 86,000 (Direct) | View |
| 2023-12-01 Disposition | 2023-12-05 5:23 pm | N/A 2026-09-15 | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director | 112,798 | $0 | 0 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 13,401 | $2.22 | 140,269 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:54 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO | 40,125 | $0 | 140,269 (Direct) | View |